EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system

Mingfei Li, Ying Wang, Tsewang Tashi, Anthony M Hunter, Ghaith Abu-Zeinah, Joel Reisman, Albert Qin, Weiming Xia

Cancer Treatment and Research Communications · 2026 · 49 · 101397

DOI: 10.1016/j.ctarc.2026.101397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Mingfei Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematical Sciences, Bentley University, Waltham, MA, USA; Center for Healthcare Optimization & Implementation, VA Bedford Healthcare…. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with polycythemia vera (PV) have increased incidence of thrombotic events (TEs) that contribute to higher mortality compared to age-matched controls. We aim to compare the impact of phlebotomy (PHL) and cytoreductive therapy (CT) on outcomes in US veterans with PV between Oct 2017 and Dec 2023. PV treatment was categorized into three groups: CT, PHL, and no documented treatment. Among 11,809 veterans with PV, 7151 (60.6%) received CT or PHL treatments. After excluding those with events before or within 90 days of index date (PV diagnosis), we identified 5287 and 5245 qualified patients to examine treatment impact on mortality and TE, respectively. The mortality rate was 15.4% (n = 816), with a median survival time of 4.5, 4.9 or 4.3 years for patients under CT, PHL only, or no treatment, respectively. The TE rate was 9.4% (n = 496), with a median duration (from index date to the first TE or censored date) of 4.2, 4.7, or 4.0 years for patients under CT, PHL, or no treatment, respectively. Both CT and PHL reduced mortality, and there was no significant difference between CT and PHL that lowered the risk of TE. Compared with patients with no documented treatment, patients treated with CT had a 43% lower risk of mortality (HR 0.57, 95% CI 0.45-0.75; p < 0.01), and patients treated with PHL had a 20% lower risk of mortality (HR 0.80, 95% CI 0.65-1.00; p = 0.05). Therefore, in patients with PV, treatment with CT had similar outcome on TE or mortality, compared to those treated with PHL.

Schlagwörter

Stichwörter der Autor:innen

Cytoreductive therapyMortalityPhlebotomyPolycythemia veraThrombotic event

Autor:innen und Institutionen

  • Department of Mathematical Sciences, Bentley University, Waltham, MA, USA; Center for Healthcare Optimization & Implementation, VA Bedford Healthcare System, Bedford, MA, USA.
  • Wentworth Institute of Technology, Boston, MA, USA; Geriatric Research Education and Clinical Center, VA Bedford Healthcare System, Bedford, MA, USA.
  • Huntsman Cancer Institute, University of Utah, Salt Lake, UT, USA.
  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10021, USA.
  • Department of Biological Sciences, University of Massachusetts Lowell, Lowell, MA, USA.

Zitieren

APA

Li, M., Wang, Y., Tashi, T., Hunter, A. M., Abu-Zeinah, G., Reisman, J., Qin, A., & Xia, W. (2026). Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system. Cancer Treatment and Research Communications, 49, 101397. https://doi.org/10.1016/j.ctarc.2026.101397

Vancouver

Li M, Wang Y, Tashi T, Hunter AM, Abu-Zeinah G, Reisman J, et al. Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system. Cancer Treatment and Research Communications. 2026;49:101397. doi:10.1016/j.ctarc.2026.101397

BibTeX
@article{Li2026,
  author = {Li, Mingfei and Wang, Ying and Tashi, Tsewang and Hunter, Anthony M and Abu-Zeinah, Ghaith and Reisman, Joel and Qin, Albert and Xia, Weiming},
  title = {Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101397},
  doi = {10.1016/j.ctarc.2026.101397}
}
Kostenlos starten →